Catherine M. Cowan
Vancouver, BC V6T1B5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
Journal: Acta neuropathologica communications
Published: October 09, 2023
Suppression of tau-induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity.
Journal: Journal of neurochemistry
Published: June 23, 2020
CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1.
Journal: The Journal of biological chemistry
Published: July 10, 2018
A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
Journal: ACS chemical neuroscience
Published: April 05, 2018
High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.
Journal: Molecular neurodegeneration
Published: May 04, 2017
Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy.
Journal: Neurobiology of disease
Published: December 01, 2016
Cadherins mediate cocaine-induced synaptic plasticity and behavioral conditioning.
Journal: Nature neuroscience
Published: August 06, 2016
Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers.
Journal: Scientific reports
Published: March 13, 2015
Are tau aggregates toxic or protective in tauopathies?
Journal: Frontiers in neurology
Published: June 13, 2013
What is the pathological significance of tau oligomers?
Journal: Biochemical Society transactions
Published: July 24, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026